ePOSSUM
ePOSSUM evaluates the impact of DNA variants on transcription factor (TF) binding sites to assess potential effects on gene regulation.
Key Features:
- In Silico Modeling: Employs position-specific scoring matrices (PSSMs) derived from JASPAR, HT-SELEX-generated models, and protein binding microarrays (PBMs) to model variant effects on TF binding.
- Systematic Comparison: Systematically compares PSSM-based models against experimentally verified in vivo TF binding sites from ENCODE ChIP-seq data.
- Performance Assessment: Assesses model performance using receiver operating characteristic (ROC) analysis and reports area-under-curve (AUC) scores, noting that only a subset reach an AUC of 0.7 or higher.
- Bayes Classifier: Incorporates a Bayes classifier to provide probabilistic evaluation of how genetic alterations affect TF binding within user-defined sequences.
- Reliability Information: Evaluates prediction reliability by referencing a test set of experimentally confirmed binding sites.
Scientific Applications:
- Gene regulation analysis: Characterizing mechanisms of gene regulation by quantifying variant-induced changes in TF binding.
- Disease variant interpretation: Prioritizing and interpreting regulatory DNA variants that may contribute to disease through altered TF binding.
- Model benchmarking and refinement: Comparing and refining TF binding models by benchmarking JASPAR, HT-SELEX, and PBM-derived PSSMs against ENCODE ChIP-seq.
Methodology:
Uses PSSMs from JASPAR, HT-SELEX, and PBM-derived models; compares them to ENCODE ChIP-seq TF binding sites; performs ROC analysis to compute AUC; and applies a Bayes classifier to assess variant effects.
Topics
Details
- Maturity:
- Mature
- Cost:
- Free of charge
- Tool Type:
- web application
- Operating Systems:
- Linux, Windows, Mac
- Added:
- 7/22/2019
- Last Updated:
- 11/24/2024
Operations
Publications
Hombach D, Schwarz JM, Robinson PN, Schuelke M, Seelow D. A systematic, large-scale comparison of transcription factor binding site models. BMC Genomics. 2016;17(1). doi:10.1186/s12864-016-2729-8. PMID:27209209. PMCID:PMC4875604.
PMID: 27209209
PMCID: PMC4875604
Funding: - Deutsche Forschungsgemeinschaft: SE2273, SFB665 TP-C4
- Stiftung Charité: BIH_PRO_313
- NeuroCure Cluster of Excellence: Exc 257
- Bundesministerium für Bildung und Forschung: 0313911
- Einsteinstiftung Berlin: A-2011-63